Cassia Cearley
Corporate Officer/Principal bei ICOSAVAX, INC.
Profil
Cassia Cearley is currently the Chief Business Officer at Icosavax, Inc. She previously worked as the Vice President-Research at Aptinyx, Inc. from 2015 to 2019.
Before that, she was a Senior Director-Development at Naurex, Inc. from 2014 to 2015.
Prior to that, she served as the Director-Portfolio Management at Takeda Pharmaceuticals U.S.A., Inc. from 2013 to 2014.
Cassia also worked as a Manager-Engagement at L.E.K.
Consulting LLC from 2007 to 2013.
She holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Washington State University.
Aktive Positionen von Cassia Cearley
| Unternehmen | Position | Beginn |
|---|---|---|
| ICOSAVAX, INC. | Corporate Officer/Principal | 01.02.2021 |
Ehemalige bekannte Positionen von Cassia Cearley
| Unternehmen | Position | Ende |
|---|---|---|
| APTINYX | Chief Tech/Sci/R&D Officer | - |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Corporate Officer/Principal | 01.01.2015 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01.01.2014 |
L.E.K. Consulting LLC
 L.E.K. Consulting LLC Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting LLC operates as a management consulting firm. It offers disruption management, post-merger integration, and marketing and sales services. The company was founded by James Lawrence, Iain Evans and Richard Koch in 1983 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Cassia Cearley
| University of Pennsylvania | Doctorate Degree |
| Washington State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APTINYX | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
L.E.K. Consulting LLC
L.E.K. Consulting LLC Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting LLC operates as a management consulting firm. It offers disruption management, post-merger integration, and marketing and sales services. The company was founded by James Lawrence, Iain Evans and Richard Koch in 1983 and is headquartered in Boston, MA. | Commercial Services |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
